insights_auto
Why is INO down 16,21%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,22 US$
arrow_downward
-16,21%(-0,24) 1D
6 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,12 US$
High
1,27 US$
Low
1,07 US$
Mkt. cap
125,63 მლნ.
Avg. vol.
17,42 მლნ.
Volume
0,00
52-wk high
2,72 US$
52-wk low
0,57 US$
EPS
-1,17 US$
Beta
1,71
Shares outstanding
103,40 მლნ.
No. of employees
112
Open
1,12 US$
High
1,27 US$
Low
1,07 US$
Mkt. cap
125,63 მლნ.
Avg. vol.
17,42 მლნ.
Volume
0,00
52-wk high
2,72 US$
52-wk low
0,57 US$
EPS
-1,17 US$
Beta
1,71
Shares outstanding
103,40 მლნ.
No. of employees
112
News stories
From web sources and news partners
Yahoo Finance
·
2 დღის წინ
Inovio stock tumbles 25% on $75M share offering
Yahoo Finance
·
3 დღის წინ
INOVIO Announces Proposed Public Offering of its Common Stock
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc